CymaBay Therapeutic (CBAY) PT Lowered to $12 at H.C. Wainwright
Tweet Send to a Friend
H.C. Wainwright analyst Ed Arce lowered the price target on CymaBay Therapeutic (NASDAQ: CBAY) to $12.00 (from $13.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
